Drugs@FDA: FDA-Approved Drugs
Abbreviated New Drug Application (ANDA): 214194
Company: AMNEAL
Company: AMNEAL
Drug Name | Active Ingredients | Strength | Dosage Form/Route | Marketing Status | TE Code | RLD | RS |
---|---|---|---|---|---|---|---|
DEFERASIROX | DEFERASIROX | 180MG | GRANULE;ORAL | Discontinued | None | No | No |
DEFERASIROX | DEFERASIROX | 360MG | GRANULE;ORAL | Discontinued | None | No | No |
DEFERASIROX | DEFERASIROX | 90MG | GRANULE;ORAL | Discontinued | None | No | No |
Original Approvals or Tentative Approvals
Action Date | Submission | Action Type | Submission Classification | Review Priority; Orphan Status | Letters, Reviews, Labels, Patient Package Insert | Notes | Url |
---|---|---|---|---|---|---|---|
02/09/2021 | ORIG-1 | Approval | STANDARD |
Label is not available on this site. |
Supplements
Action Date | Submission | Supplement Categories or Approval Type | Letters, Reviews, Labels, Patient Package Insert | Note | Url |
---|---|---|---|---|---|
08/02/2021 | SUPPL-1 | Labeling-Container/Carton Labels, Labeling-Package Insert |
Label is not available on this site. |